Who
Micah W. Young
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, QuidelOrtho; EVP, Chief Financial Officer, Masimo.
In numbers
- Trades disclosed
- 89
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $8.2M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 16 Oct 2017
- Last trade
- 15 Jul 2026
- Last filed
- 16 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 16 Jul 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —356,555 at $0.00 | filing |
| 15 Jul 2026filed 16 Jul 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —356,555 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | MasimoMedical Devices | SEC FORM 4 Code D | $4.6M25,656 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | $104K7,739 at $13.48 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | $3.0M16,898 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | $1.9M10,485 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —2,622 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —17,671 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —2,622 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —17,671 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $1.9M20,000 at $95.03 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $388K4,175 at $93.05 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $269K5,788 at $46.50 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $3,8476,633 at $0.58 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $143K6,362 at $22.47 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $640K11,954 at $53.51 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $104K7,739 at $13.48 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $3.0M16,898 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | $1.9M10,485 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | $1.9M20,000 at $95.03 | filing |
News
No headline names them, or the companies they trade most, lately.